# Boston Scientific to Acquire Penumbra for $14.5 Billion

> ma · REPORTED · 2026-06-27

Boston Scientific announced plans to acquire Penumbra for $14.5 billion, adding the neurovascular and peripheral vascular device maker to its portfolio in one of the largest medtech deals in recent years. The transaction is Boston Scientific's second major acquisition of 2026 following its agreement to acquire Valencia Technologies.

About Boston Scientific: Penumbra is a medical device company that develops and markets minimally invasive therapies for the treatment of vascular and neurovascular conditions, including stroke thrombectomy and peripheral embolectomy systems.

- Company: Boston Scientific
- Sector: medical devices
- Primary source: https://www.medtechdive.com/news/medtech-ma-took-off-in-the-second-half-of-2025-report/810731/

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.